Developer docs
API playgroundTry for free, no card

Search company profiles

Cube Biotech

Full company profile

uuid0006mbh

Namestring
Cube Biotech
Legal namestring
Cube Biotech GmbH
Company typeenum
Private
Founded yearint
2012
Descriptiontext

Cube Biotech GmbH is a German biotechnology tools company founded in 2012 and headquartered in Monheim am Rhein, specializing in reagents, kits, and contract services for membrane protein research. Its proprietary NativeMP™ platform uses a portfolio of more than 30 synthetic copolymers (including Cubipol, AASTY, DIBMA, SMA, and Ultrasolute™ Amphipol) that form polymer nanodiscs around membrane proteins, preserving their native lipid environment in place of traditional detergents — a workflow that the company demonstrates is compatible with cryo-EM, X-ray crystallography, AS-MS, phage display, and antibody discovery. The company also markets protein purification consumables (PureCube Ni-INDIGO and Ni-NTA affinity resins, HighSpec Rho1D4 immunoaffinity resins, Strep-Tactin®XT/Twin-Strep-tag® products acquired via IBA Lifesciences), ready-to-run automation plates (NativeMP™ Plates on KingFisher Flex; PlateX MP™ on INTEGRA and Analytik Jena robots), and premium off-the-shelf NativeMP™ Targets such as ABCA1, ADRB2, GLP1R, and P2X4 priced up to US$17,760.

The company operates a multi-channel go-to-market combining a direct e-commerce storefront, US distribution via Fisher Scientific and VWR/Avantor, an international distributor network, and a US sales/logistics operation managed by Percorso Life Sciences. Revenue is generated through four streams: catalog consumables and kits sold at unit pricing, OEM/bulk custom agarose and bead production, quote-based fee-for-service custom membrane protein CRO work, and high-value NativeMP™ Target sales. Strategic customers include Bayer (crop-science use case), Orion Pharma (structural biology), Orogen Therapeutics, Allegria Therapeutics, Fraunhofer ITMP, and ProteoGenix, alongside more than 100 academic and research institutions. The company is privately held and backed by healthcare-focused private equity firm ARCHIMED, which invested in 2022 and placed Denis Ribon as Chairman. Cube Biotech completed the acquisition of IBA Lifesciences in January 2025, appointed former Sartorius CEO Joachim Kreuzburg to its board in Summer 2025, and secured the SLAS 2026 Europe New Product Award for PlateX MP™ in May 2026.

Short descriptiontext

Cube Biotech is a Germany-based biotechnology tools company that develops NativeMP™ copolymer reagents, affinity purification resins, automated membrane protein purification plates, and CRO services for pharma, biotech, and academic researchers working on membrane protein drug discovery and structural biology.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersMonheim, Germany
HQ citystring
Monheim
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
membrane protein stabilization, protein purification reagents, copolymer nanodisc technology, affinity chromatography resins, cryo-EM sample preparation
Industry2 codes
PRIMARYHLAGAAAD
Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity)
SECONDARYHLAAAJAI
Bioprocess Consumables & Reagents (resins, membranes, media components, buffers)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
NAICS code2 codes
  • Biological Product (except Diagnostic) Manufacturing325414
  • Packaging and Labeling Services56191
SIC code2 codes
  • Biological Products, (No Disgnostic Substances)2836
  • Services-Medical Laboratories8071
Product category
Membrane Protein Research Reagents
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model4 records
1Catalog Product Sales (Consumables & Kits)
TypeOne Time License
Description

Direct one-time sales of catalog products (copolymers, nanodiscs, affinity resins, MagBeads, purification kits, NativeMP™ plates, PlateX MP™ plates, target proteins) via the company's online shop with publicly listed US dollar prices. Product examples include AASTY at $473, Cubipol at $695, MSP1D1-His at $204, NativeMP™ Rho1D4 Purification Plate at $1,158.

cube-biotech.com
2Custom Membrane Protein CRO Services
TypeProfessional Services
Description

Quote-based fee-for-service custom protein expression, solubilization, stabilization, purification, and characterization projects for clients including pharma, biotech, and academia. Includes NativeMP™ platform projects (acquire complex membrane protein targets within weeks). Pricing not publicly disclosed.

cube-biotech.com
3OEM / Bulk Product Sales
TypeOne Time License
Description

Bulk quantities of agarose resins, magnetic beads, customized agaroses and magnetic beads, and nanodisc products provided to larger biotech and research institutes on-demand.

cube-biotech.com
4NativeMP™ Target Protein Sales (High-value Catalog)
TypeOne Time License
Description

Premium-priced off-the-shelf membrane protein targets (e.g., ABCA1 at $15,360, ADRB2, GLP1R, P2X4) sold to pharma/biotech for drug discovery. Targets include GPCRs, transporters, ion channels, receptors, claudins, integrins.

cube-biotech.com
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
Pricing details8 tiers
1Catalog copolymer products (AASTY 11-45 etc.) priced per unit in the hundreds of USD
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Example prices: AASTY 11-45 at US$473.00; AASTY 11-50 Biotin at US$1,142.00; AASTY Screening Kit (6x2x50 mg) at US$384.00.

cube-biotech.com
2Premium next-gen Cubipol copolymer reagents
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Example prices: Cubipol at US$695.00; Cubipol Biotin at US$1,388.00.

cube-biotech.com
3Protein purification kits and reagents (His, Rho1D4, Strep-Tactin)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Example prices: MSP1D1-His lyophilized protein at US$204; HighSpec Rho1D4 Agarose at US$2,317; HisCube Ni-INDIGO MIDI Kit at US$799; MagStrep®XT beads at US$312. Buffer/Kit pricing: 10x Buffer BXT US$89, Buffer XT-R US$92, 10x Buffer W US$69.

cube-biotech.com
4Proteomics and phosphopeptide enrichment products
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Example prices: GentleLys Native Cell Lysis Buffer US$240; PureCube Al-NTA Agarose US$192; PureCube Al-NTA MagBeads US$536; PureCube Fe-NTA MagBeads US$126.

cube-biotech.com
5NativeMP™ off-the-shelf protein targets (premium pricing)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Example prices: ABCA1 Phospholipid-transporting ATPase US$15,360; ABCA12 Glucosylceramide transporter US$17,760 / US$15,100; ABCA4 Retinal-specific phospholipid-transporting ATPase US$13,060; ABCB1 ATP-dependent translocase US$12,960 / US$11,020; AChR T. Californica US$1,542. EU and US price PDFs available.

cube-biotech.com
6NativeMP™ Screening & Purification Plates (KingFisher)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Example prices: NativeMP™ Rho1D4 Purification Plate 96-well 2x at US$1,132, 4x at US$2,207, 6x at US$3,225; NativeMP™ Strep-Tactin®XT Purification Plate 2x US$1,626, 4x US$3,171, 6x US$4,634; NativeMP™ Anti-DYKDDDDK Purification Plate 2x US$1,721, 4x US$2,906(?), 6x US$4,906; Screening Plates 2x US$730, 4x US$1,423, 6x US$2,080; Screening+Purification Plate Sets range from US$1,182 to US$4,783.

cube-biotech.com
7PlateX MP™ ready-to-run MagBead plates for liquid handling robots
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Example price: PlateX MP™ Anti-DYKDDDDK MagBeads at US$594.00. Available in Axygen (1x) and INTEGRA (6x) formats for Rho1D4, DYKDDDDK, and Strep-Tactin®XT tags. Custom pricing via sales contact.

cube-biotech.com
8Custom membrane protein CRO services (quote-based)
ModelOtherBilling cadencePay-as-you-go
Notes

Custom protein expression, solubilization, stabilization, purification, characterization and drug target pipeline projects are quote-based via 'Request a Quote' on the website. Pricing not publicly disclosed.

cube-biotech.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 7 records shown
1NativeMP™
Description

Proprietary membrane protein stabilization technology platform using copolymer nanodiscs to keep membrane proteins in their native lipid environment.

cube-biotech.com
+6 more records
Core offering1 text field

Cube Biotech develops, manufactures, and sells proprietary copolymer-based NativeMP™ reagents and consumables for stabilizing membrane proteins in their native lipid environment, complemented by affinity purification resins (PureCube Ni-INDIGO, Ni-NTA, Rho1D4, Strep-Tactin®XT), automated 96-well screening and purification plates (PlateX MP™ for liquid handling robots; NativeMP™ Plates for KingFisher Flex), off-the-shelf NativeMP™ stabilized protein targets, and quote-based custom membrane protein expression / purification CRO services. Its products are used by over 100 research institutions and pharmaceutical/biotech companies worldwide for cryo-EM, X-ray crystallography, antibody discovery, and drug discovery.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 20× higher yield in 90 minutes vs. 20 hours manual workflow (NativeMP™ Plates)
+6 more records
Product and service17 records
1PlateX MP™ Plates
CategoryAutomation reagent / Membrane protein purification plate
Description

Ready-to-run, lyophilized deep-well plates preloaded with 8 Cubipol copolymers plus Rho1D4, Anti-DYKDDDDK, or Strep-Tactin®XT MagBeads, enabling automated membrane protein screening and purification on INTEGRA and Analytik Jena liquid handling robots in approximately 2 hours. Built on five Cube Biotech patents; designed for pharma, biotech, and academic labs needing hands-off workflows.

2NativeMP™ Screening & Purification Plates (KingFisher™)
CategoryAutomation reagent / Membrane protein screening and purification plate
Description

Pre-filled 96 deep-well plates designed for the KingFisher Flex system, combining a NativeMP™ Screening Plate (16 selected copolymers) with tag-matched Purification Plates (Rho1D4, Strep-Tactin®XT, or Anti-DYKDDDDK) for parallel screening and purification of 2, 4, or 6 membrane protein targets in approximately 90 minutes, versus 20 hours manually.

3NativeMP™ Targets (off-the-shelf stabilized membrane protein targets)
CategoryCatalog offering / Stabilized membrane protein target
Description

Off-the-shelf, full-length, active GPCRs, ion channels, aquaporins, ABC transporters, claudins, integrins, SLC transporters, and tetraspanins stabilized in copolymer nanodiscs, sold as ready-to-use assay positive controls or starting material for biophysical, biochemical, and cryo-EM studies by pharma and biotech drug-discovery teams.

4Cubipol Series Copolymers (Cubipol, Sulfo-Cubipol, Cubipol Biotin, Cubipol Amine, Cubipol Fluorescein, Cubipol Glycerol, Glyco-Cubipol, Cubipol PEG)
CategoryCopolymer / Membrane protein stabilization reagent
Description

Next-generation synthetic copolymers that form copolymer nanodiscs solubilizing and stabilizing membrane proteins in their native lipid environment; used in PlateX MP™ plates and as standalone reagents (e.g., Cubipol at US$695, Cubipol Biotin at US$1,388). Sulfo-Cubipol enabled the first human P2X4 cryo-EM structure.

5AASTY Copolymers (AASTY 6-45, 6-50, 6-55, 11-45, 11-50, 11-55, plus biotinylated variants)
CategoryCopolymer / Membrane protein stabilization reagent
Description

Next-generation AASTY copolymers for solubilizing and stabilizing membrane proteins in copolymer nanodiscs; sold per vial with biotinylated and screening-kit variants for use by pharma, biotech, and academic labs.

6DIBMA Copolymers (DIBMA 6, DIBMA 10, DIBMA 12, plus Glucosamine, Glycerol, Biotin, and Fluorescein variants)
CategoryCopolymer / Membrane protein stabilization reagent
Description

Synthetic DIBMA copolymers for membrane protein stabilization in copolymer nanodiscs, offered in multiple chain lengths and functionalized variants for diverse membrane protein targets and labeling workflows.

7SMA Copolymers (SMALPs)
CategoryCopolymer / Membrane protein stabilization reagent
Description

Styrene-maleic acid (SMA) copolymers forming SMA-Lipid-Particles (SMALPs) for detergent-free extraction and stabilization of membrane proteins; the foundational chemistry behind the SMALP method, including the second-generation SMALP BZ series co-developed with Prof. Bert Klumperman.

8Ultrasolute™ Amphipol Copolymers
CategoryAmphipol / Membrane protein stabilization reagent
Description

Next-generation amphipol copolymers (e.g., Ultrasolute™ Amphipol 18) sold as part of the NativeMP™ screening portfolio for membrane protein stabilization in cryo-EM and functional studies.

9MSP Nanodisc Products (MSP1D1-His and pre-assembled nanodiscs)
CategoryNanodisc scaffold / Membrane protein reagent
Description

Membrane scaffold protein (MSP) reagents such as MSP1D1-His lyophilized protein and pre-assembled nanodiscs for classical MSP-based membrane protein reconstitution, used as an alternative to copolymer-based NativeMP™ workflows.

10Ultrapure Detergents
CategoryDetergent / Membrane protein reagent
Description

Ultrapure-grade detergents for solubilization and stabilization of membrane proteins, sold as the conventional alternative to copolymer nanodiscs in the NativeMP™ workflow.

11PureCube Ni-INDIGO His-Tag Affinity Resins & MagBeads
CategoryAffinity purification resin / His-tag purification
Description

Ni-INDIGO His-tag affinity agarose resins and magnetic beads offering up to 30× lower Ni leakage versus conventional Ni-NTA, with EDTA/DTT resistance, 80–100 mg/mL binding capacity, and 0.5 M NaOH CIP without stripping nickel; available as agarose, MagBeads, and complete kits (e.g., HisCube Ni-INDIGO MIDI Kit at US$799).

12PureCube Ni-NTA Affinity Resins & MagBeads
CategoryAffinity purification resin / His-tag purification
Description

High ligand-density Ni-NTA agarose and MagBeads for His-tag protein purification, providing >20% higher binding capacity than leading competitor Ni-NTA materials, used by labs needing high-yield routine His-tag purification.

13HighSpec Rho1D4 Affinity Resins & MagBeads
CategoryImmunoaffinity purification resin / Rho1D4-tag purification
Description

High-purity Rho1D4 immunoaffinity agarose, MagBeads, FPLC columns, peptide, and antibody products with KD ≈ 20 nM, used for membrane protein purification in cryo-EM workflows by pharma, biotech, and academic structural biology labs.

14Strep-Tactin®XT Affinity Resins & MagBeads (incl. MagStrep®)
CategoryAffinity purification resin / Strep-tag purification
Description

Twin-Strep-tag®/Strep-Tactin®XT agarose and MagStrep®XT magnetic beads delivering >95% protein purity with picomolar affinity and binding capacities up to 31 mg/mL (agarose) or 42.5 mg/mL (magnetic beads); integrated into Cube Biotech's catalog following the January 2025 acquisition of IBA Lifesciences.

15GST-Tag Affinity Resins & MagBeads
CategoryAffinity purification resin / GST-tag purification
Description

GST-tag affinity agarose resins, MagBeads, and GST-eGFP fusion proteins (DYKDDDDK- or Rho1D4-tagged) for GST-tagged protein purification and assay development.

16Custom Membrane Protein Services (CRO)
CategoryCustom CRO service / Membrane protein expression and purification
Description

Quote-based custom protein expression, solubilization, stabilization, purification, and characterization services delivered via the NativeMP™ platform; engagements include dedicated project managers and co-development with partners such as Bayer (Slo protein for eco-friendly pesticides). Pricing is quote-based.

17Drug Target Pipeline Service
CategoryDrug discovery pipeline service
Description

Drug Target Pipeline service combining NativeMP™ membrane protein targets with fast-track drug discovery partners spanning target identification through hit-to-lead, including AI-driven (Iktos), DNA-encoded library (X-Chem), antibody (Isogenica), AS-MS (Momentum Biotechnologies), and small-molecule (edelris) capabilities.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership17 partners
1Joachim Kreuzburg
Strategic tierCoreTypeOthersAnnounced on2025-07-01
Description

Joachim Kreuzburg (former Sartorius CEO) joined the Cube Biotech Board of Directors in summer 2025. Announcement on the News page: 'Joachim Kreuzburg joins Board of Directors — Board Update Summer 2025'.

cube-biotech.com
2IBA Lifesciences
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Cube Biotech completed the acquisition of IBA Lifesciences, with announcements titled 'Cube Biotech Completes Acquisition of IBA Lifesciences — Two leading innovators of biotech join forces' and 'We're Growing Better Together! Cube Biotech and IBA Lifesciences have joined forces!' (pop-up banner and News tile on the homepage). The two organizations now jointly market Strep-Tactin®XT and Twin-Strep-tag® products.

cube-biotech.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Co-development partnership with Bayer to develop eco-friendly pesticides using Cube Biotech's NativeMP™ platform to work on the Slo protein. Case study featured on the Membrane Protein Service page under 'Slo Protein for Bayer — We are developing eco-friendly pesticides to elevate agriculture to the next level'.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic partnership with Orion Pharma (Espoo, Finland); referenced customer in R&D Target Pipeline with testimonial from Dr. Josef Messinger, Head of Structural Biology and Analytics. Logo featured on the Cube Biotech homepage and partner carousel.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic partnership series: Part II. Joint work on mass spectrometry-based drug discovery for membrane-bound proteins. Co-presented webinar 'Affinity Selection Mass Spectrometry (ASMS) High-Throughput Screening of the GLP1 Receptor' identifying small-molecule binders of GLP1R using NativeMP™ + customized AS-MS workflow.

Strategic tierCoreTypeTechnology or Integration
Description

Strategic technology partnership. Jointly published multiple application notes (App Note on NativeMP™ & Monolith X; App Note on NativeMP™ & Prometheus Panta for Cryo-EM workflows; App Note with Imperiali Lab at MIT for copolymer screening). Co-hosted webinars 'Optimization of Membrane Proteins for Cryo-EM with Nanotemper' and 'Breaking barriers in membrane protein drug discovery'.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic partnership series: Part V (September 2025). X-Chem is featured on the Drug Target Pipeline page as a fast-track drug discovery partner spanning target identification through hit-to-lead. Logo featured on the homepage partner carousel.

8Iktos
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Strategic partnership series: Part III. AI-driven drug discovery collaboration; logo and announcement featured on the News page.

cube-biotech.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Strategic partnership series: Part IV. Antibody / biologics discovery collaboration; featured as a news announcement on cube-biotech.com.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Strategic partnership series: Part I. Cryo-EM services collaboration; featured as a news announcement on the Cube Biotech website.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership to produce target-specific antibodies via NativeMP™ platform plus ProteoGenix's phage display libraries and Xtencho™ platform. Co-developed 2 fully human antibodies against native human P2X4 (available for licensing). Co-hosted Intelligent Infusions webinar 'Next-Gen Antibody Discovery Enabled by the NativeMP™ & Phage Display Technology — P2X4 Case Study'.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Featured partner on the Drug Target Pipeline page (Fast-track drug discovery partners). Provides complementary drug discovery capabilities for the Cube Biotech pipeline.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Consortium partner with Cube Biotech and Fraunhofer ITMP in the MastCURe research consortium. Awarded €1.3M from the Eureka Eurostars program (April 2026) to develop novel mast-cell directed therapies for chronic urticaria, targeting aberrant mast cell activation in over 60 million patients worldwide.

14Fraunhofer Institute for Translational Medicine and Pharmacology ITMP (Immunology and Allergology)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Consortium partner in the MastCURe research consortium with Allegria Therapeutics and Cube Biotech. Co-recipient of €1.3M Eureka Eurostars funding (April 2026) for mast-cell directed therapies for chronic urticaria.

prnewswire.com
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Percorso Life Sciences has assisted Cube Biotech with their North American operations since 2013 (almost 10 years). Percorso facilitates order processing, inventory management and provides sales channels into the North American Life Science, Biotech and Pharmaceutical markets.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Cube Biotech products distributed globally via Fisher Scientific catalog (fishersci.com); prominently featured as 'Buy also at' partner on multiple product pages.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Cube Biotech products distributed via VWR / Avantor storefronts (us.vwr.com and avantorsciences.com); featured as 'Buy also at' partner on multiple product pages.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Anatrace (acquired by Thermo Fisher Scientific) manufactures high-purity detergents and membrane protein reagents that are the conventional alternative to Cube Biotech's NativeMP™ copolymer nanodiscs. Both companies serve the same membrane protein research and structural biology customer base with overlapping product categories for GPCR, ion channel, and transporter workflows.

TypeDirect peer
Description

Avanti Polar Lipids (acquired by Croda) supplies lipids, detergents, and lipid nanoparticles for membrane protein research, cryo-EM, and drug delivery — directly adjacent to Cube Biotech's membrane protein stabilization and NativeMP™ copolymer portfolio. Both serve academic and pharma membrane protein labs with complementary lipid- and polymer-based tools.

3IBA Lifesciences
TypeDirect peer
Description

IBA Lifesciences was acquired by Cube Biotech in 2025 and remains a key product brand within the combined portfolio. Prior to the acquisition it was a direct peer offering Strep-Tactin®XT / Twin-Strep-tag® affinity purification tools, and the two companies' customer bases and product lines are now fully integrated.

TypeBroad incumbent
Description

Cytiva (formerly GE Healthcare Life Sciences) is a large incumbent in protein purification and life sciences tools with broad portfolios in affinity chromatography, magnetic beads, and bioprocessing that overlap with Cube Biotech's PureCube Ni-INDIGO, Rho1D4, and Strep-Tactin®XT product lines. Cytiva competes on scale, catalog breadth, and bundled pricing in the same pharma and academic accounts.

TypeBroad incumbent
Description

Bio-Techne (NASDAQ: TECH) is a large protein research tools company offering recombinant proteins, antibodies, and assay reagents that overlap with Cube Biotech's NativeMP™ Targets catalog and Protein Service CRO offerings. Bio-Techne competes on catalog breadth and global distribution in academic and pharma protein research.

TypeBroad incumbent
Description

Sartorius is a major bioprocessing and lab products company offering protein purification, cell line development, and bioprocess tools that overlap with Cube Biotech's downstream purification portfolio and CRO services. The cross-membership of former Sartorius CEO Joachim Kreuzburg on Cube Biotech's Board underscores the strategic adjacency between the two companies in bioprocess and protein sciences.

TypeBroad incumbent
Description

Promega is a privately held life-sciences tools company offering protein analysis, purification, and detection reagents with overlapping applications in protein purification (His-tag, GST-tag) and cell-based assays. Promega competes with Cube Biotech's PureCube affinity resin line in mid-market and academic labs.

8Merck KGaA (Sigma-Aldrich)
TypeBroad incumbent
Description

Merck KGaA's life science business (including Sigma-Aldrich) is a global incumbent in research chemicals, reagents, and consumables with overlapping product categories in protein purification detergents, affinity resins, and standards. Sigma-Aldrich competes with Cube Biotech across academic and pharma catalog procurement.

TypeBroad incumbent
Description

Lonza is a large contract development and manufacturing organization with adjacent capabilities in cell line engineering, protein expression, and bioprocess services. Lonza's protein production services overlap with Cube Biotech's CRO offering and drug target pipeline, and Lonza serves a similar pharma/biotech customer base.

TypeEmerging player
Description

NanoTemper Technologies is a strategic technology partner of Cube Biotech with joint application notes on NativeMP™ and Monolith X (MST) and NativeMP™ and Prometheus Panta for Cryo-EM workflows. The companies jointly enable membrane protein characterization workflows, positioning NanoTemper as a complementary rather than directly competing peer.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers13 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cube Biotech

Membrane Protein Research Reagentscube-biotech.com

Cube Biotech is a Germany-based biotechnology tools company that develops NativeMP™ copolymer reagents, affinity purification resins, automated membrane protein purification plates, and CRO services for pharma, biotech, and academic researchers working on membrane protein drug discovery and structural biology.

What Cube Biotech does

Cube Biotech GmbH is a German biotechnology tools company founded in 2012 and headquartered in Monheim am Rhein, specializing in reagents, kits, and contract services for membrane protein research. Its proprietary NativeMP™ platform uses a portfolio of more than 30 synthetic copolymers (including Cubipol, AASTY, DIBMA, SMA, and Ultrasolute™ Amphipol) that form polymer nanodiscs around membrane proteins, preserving their native lipid environment in place of traditional detergents — a workflow that the company demonstrates is compatible with cryo-EM, X-ray crystallography, AS-MS, phage display, and antibody discovery. The company also markets protein purification consumables (PureCube Ni-INDIGO and Ni-NTA affinity resins, HighSpec Rho1D4 immunoaffinity resins, Strep-Tactin®XT/Twin-Strep-tag® products acquired via IBA Lifesciences), ready-to-run automation plates (NativeMP™ Plates on KingFisher Flex; PlateX MP™ on INTEGRA and Analytik Jena robots), and premium off-the-shelf NativeMP™ Targets such as ABCA1, ADRB2, GLP1R, and P2X4 priced up to US$17,760.

The company operates a multi-channel go-to-market combining a direct e-commerce storefront, US distribution via Fisher Scientific and VWR/Avantor, an international distributor network, and a US sales/logistics operation managed by Percorso Life Sciences. Revenue is generated through four streams: catalog consumables and kits sold at unit pricing, OEM/bulk custom agarose and bead production, quote-based fee-for-service custom membrane protein CRO work, and high-value NativeMP™ Target sales. Strategic customers include Bayer (crop-science use case), Orion Pharma (structural biology), Orogen Therapeutics, Allegria Therapeutics, Fraunhofer ITMP, and ProteoGenix, alongside more than 100 academic and research institutions. The company is privately held and backed by healthcare-focused private equity firm ARCHIMED, which invested in 2022 and placed Denis Ribon as Chairman. Cube Biotech completed the acquisition of IBA Lifesciences in January 2025, appointed former Sartorius CEO Joachim Kreuzburg to its board in Summer 2025, and secured the SLAS 2026 Europe New Product Award for PlateX MP™ in May 2026.

Cube Biotech firmographics

Firmographics
Name
Cube Biotech
Legal name
Cube Biotech GmbH
Website
https://cube-biotech.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
51–100 employees
Short description
Cube Biotech is a Germany-based biotechnology tools company that develops NativeMP™ copolymer reagents, affinity purification resins, automated membrane protein purification plates, and CRO services for pharma, biotech, and academic researchers working on membrane protein drug discovery and structural biology.
Ownership category
akta.pro rank

Cube Biotech industry classification

Industry
Product category
Membrane Protein Research Reagents
NAICS
Biological Product (except Diagnostic) Manufacturing (325414), Packaging and Labeling Services (56191)
SIC
Biological Products, (No Disgnostic Substances) (2836), Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAGAAAD
Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity)
SECONDARYHLAAAJAI
Bioprocess Consumables & Reagents (resins, membranes, media components, buffers)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)

Keywords

  • Membrane protein stabilization
  • Protein purification reagents
  • Copolymer nanodisc technology
  • Affinity chromatography resins
  • Cryo-EM sample preparation

Where Cube Biotech is headquartered

Location

Headquarters

HQ city
Monheim
HQ country
Germany
HQ region
Europe

Markets served

Cube Biotech business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Catalog Product Sales (Consumables & Kits): Direct one-time sales of catalog products (copolymers, nanodiscs, affinity resins, MagBeads, purification kits, NativeMP™ plates, PlateX MP™ plates, target proteins) via the company's online shop with publicly listed US dollar prices. Product examples include AASTY at $473, Cubipol at $695, MSP1D1-His at $204, NativeMP™ Rho1D4 Purification Plate at $1,158.
  2. Custom Membrane Protein CRO Services: Quote-based fee-for-service custom protein expression, solubilization, stabilization, purification, and characterization projects for clients including pharma, biotech, and academia. Includes NativeMP™ platform projects (acquire complex membrane protein targets within weeks). Pricing not publicly disclosed.
  3. OEM / Bulk Product Sales: Bulk quantities of agarose resins, magnetic beads, customized agaroses and magnetic beads, and nanodisc products provided to larger biotech and research institutes on-demand.
  4. NativeMP™ Target Protein Sales (High-value Catalog): Premium-priced off-the-shelf membrane protein targets (e.g., ABCA1 at $15,360, ADRB2, GLP1R, P2X4) sold to pharma/biotech for drug discovery. Targets include GPCRs, transporters, ion channels, receptors, claudins, integrins.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goCatalog copolymer products (AASTY 11-45 etc.) priced per unit in the hundreds of USD
Unit PricingPay-as-you-goPremium next-gen Cubipol copolymer reagents
Unit PricingPay-as-you-goProtein purification kits and reagents (His, Rho1D4, Strep-Tactin)
Unit PricingPay-as-you-goProteomics and phosphopeptide enrichment products
Unit PricingPay-as-you-goNativeMP™ off-the-shelf protein targets (premium pricing)
Unit PricingPay-as-you-goNativeMP™ Screening & Purification Plates (KingFisher)
Unit PricingPay-as-you-goPlateX MP™ ready-to-run MagBead plates for liquid handling robots
OtherPay-as-you-goCustom membrane protein CRO services (quote-based)

Go-to-market motion4 records

Distribution channels6 records

Marketing channels10 records

Cube Biotech product offering

Product offering

Core offering

Cube Biotech develops, manufactures, and sells proprietary copolymer-based NativeMP™ reagents and consumables for stabilizing membrane proteins in their native lipid environment, complemented by affinity purification resins (PureCube Ni-INDIGO, Ni-NTA, Rho1D4, Strep-Tactin®XT), automated 96-well screening and purification plates (PlateX MP™ for liquid handling robots; NativeMP™ Plates for KingFisher Flex), off-the-shelf NativeMP™ stabilized protein targets, and quote-based custom membrane protein expression / purification CRO services. Its products are used by over 100 research institutions and pharmaceutical/biotech companies worldwide for cryo-EM, X-ray crystallography, antibody discovery, and drug discovery.

Differentiator

Problem solved

Functional benefit

Brands

  • NativeMP™: Proprietary membrane protein stabilization technology platform using copolymer nanodiscs to keep membrane proteins in their native lipid environment.
  • PlateX MP™
  • PureCube
  • HighSpec
  • HisCube
  • Cubipol
  • Ultrasolute™

Products and services

  • PlateX MP™ Plates Ready-to-run, lyophilized deep-well plates preloaded with 8 Cubipol copolymers plus Rho1D4, Anti-DYKDDDDK, or Strep-Tactin®XT MagBeads, enabling automated membrane protein screening and purification on INTEGRA and Analytik Jena liquid handling robots in approximately 2 hours. Built on five Cube Biotech patents; designed for pharma, biotech, and academic labs needing hands-off workflows.
  • NativeMP™ Screening & Purification Plates (KingFisher™) Pre-filled 96 deep-well plates designed for the KingFisher Flex system, combining a NativeMP™ Screening Plate (16 selected copolymers) with tag-matched Purification Plates (Rho1D4, Strep-Tactin®XT, or Anti-DYKDDDDK) for parallel screening and purification of 2, 4, or 6 membrane protein targets in approximately 90 minutes, versus 20 hours manually.
  • NativeMP™ Targets (off-the-shelf stabilized membrane protein targets) Off-the-shelf, full-length, active GPCRs, ion channels, aquaporins, ABC transporters, claudins, integrins, SLC transporters, and tetraspanins stabilized in copolymer nanodiscs, sold as ready-to-use assay positive controls or starting material for biophysical, biochemical, and cryo-EM studies by pharma and biotech drug-discovery teams.
  • Cubipol Series Copolymers (Cubipol, Sulfo-Cubipol, Cubipol Biotin, Cubipol Amine, Cubipol Fluorescein, Cubipol Glycerol, Glyco-Cubipol, Cubipol PEG) Next-generation synthetic copolymers that form copolymer nanodiscs solubilizing and stabilizing membrane proteins in their native lipid environment; used in PlateX MP™ plates and as standalone reagents (e.g., Cubipol at US$695, Cubipol Biotin at US$1,388). Sulfo-Cubipol enabled the first human P2X4 cryo-EM structure.
  • AASTY Copolymers (AASTY 6-45, 6-50, 6-55, 11-45, 11-50, 11-55, plus biotinylated variants) Next-generation AASTY copolymers for solubilizing and stabilizing membrane proteins in copolymer nanodiscs; sold per vial with biotinylated and screening-kit variants for use by pharma, biotech, and academic labs.
  • DIBMA Copolymers (DIBMA 6, DIBMA 10, DIBMA 12, plus Glucosamine, Glycerol, Biotin, and Fluorescein variants) Synthetic DIBMA copolymers for membrane protein stabilization in copolymer nanodiscs, offered in multiple chain lengths and functionalized variants for diverse membrane protein targets and labeling workflows.
  • SMA Copolymers (SMALPs) Styrene-maleic acid (SMA) copolymers forming SMA-Lipid-Particles (SMALPs) for detergent-free extraction and stabilization of membrane proteins; the foundational chemistry behind the SMALP method, including the second-generation SMALP BZ series co-developed with Prof. Bert Klumperman.
  • Ultrasolute™ Amphipol Copolymers Next-generation amphipol copolymers (e.g., Ultrasolute™ Amphipol 18) sold as part of the NativeMP™ screening portfolio for membrane protein stabilization in cryo-EM and functional studies.
  • MSP Nanodisc Products (MSP1D1-His and pre-assembled nanodiscs) Membrane scaffold protein (MSP) reagents such as MSP1D1-His lyophilized protein and pre-assembled nanodiscs for classical MSP-based membrane protein reconstitution, used as an alternative to copolymer-based NativeMP™ workflows.
  • Ultrapure Detergents Ultrapure-grade detergents for solubilization and stabilization of membrane proteins, sold as the conventional alternative to copolymer nanodiscs in the NativeMP™ workflow.
  • PureCube Ni-INDIGO His-Tag Affinity Resins & MagBeads Ni-INDIGO His-tag affinity agarose resins and magnetic beads offering up to 30× lower Ni leakage versus conventional Ni-NTA, with EDTA/DTT resistance, 80–100 mg/mL binding capacity, and 0.5 M NaOH CIP without stripping nickel; available as agarose, MagBeads, and complete kits (e.g., HisCube Ni-INDIGO MIDI Kit at US$799).
  • PureCube Ni-NTA Affinity Resins & MagBeads High ligand-density Ni-NTA agarose and MagBeads for His-tag protein purification, providing >20% higher binding capacity than leading competitor Ni-NTA materials, used by labs needing high-yield routine His-tag purification.
  • HighSpec Rho1D4 Affinity Resins & MagBeads High-purity Rho1D4 immunoaffinity agarose, MagBeads, FPLC columns, peptide, and antibody products with KD ≈ 20 nM, used for membrane protein purification in cryo-EM workflows by pharma, biotech, and academic structural biology labs.
  • Strep-Tactin®XT Affinity Resins & MagBeads (incl. MagStrep®) Twin-Strep-tag®/Strep-Tactin®XT agarose and MagStrep®XT magnetic beads delivering >95% protein purity with picomolar affinity and binding capacities up to 31 mg/mL (agarose) or 42.5 mg/mL (magnetic beads); integrated into Cube Biotech's catalog following the January 2025 acquisition of IBA Lifesciences.
  • GST-Tag Affinity Resins & MagBeads GST-tag affinity agarose resins, MagBeads, and GST-eGFP fusion proteins (DYKDDDDK- or Rho1D4-tagged) for GST-tagged protein purification and assay development.
  • Custom Membrane Protein Services (CRO) Quote-based custom protein expression, solubilization, stabilization, purification, and characterization services delivered via the NativeMP™ platform; engagements include dedicated project managers and co-development with partners such as Bayer (Slo protein for eco-friendly pesticides). Pricing is quote-based.
  • Drug Target Pipeline Service Drug Target Pipeline service combining NativeMP™ membrane protein targets with fast-track drug discovery partners spanning target identification through hit-to-lead, including AI-driven (Iktos), DNA-encoded library (X-Chem), antibody (Isogenica), AS-MS (Momentum Biotechnologies), and small-molecule (edelris) capabilities.

Quantifiable outcome

  • 20× higher yield in 90 minutes vs. 20 hours manual workflow (NativeMP™ Plates)
  • +6 more outcomes

Companies that use Cube Biotech

Customer profile

Named customers13 records

Segments4 records

Ideal customer profiles3 records

Cube Biotech technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

Feature8 records

Cube Biotech partnerships and signals

Strategic signal

Partnerships

17 partnerships are on record, tiered core, flagship and minor.

  • Joachim KreuzburgcoreOthers · 1 July 2025Joachim Kreuzburg (former Sartorius CEO) joined the Cube Biotech Board of Directors in summer 2025. Announcement on the News page: 'Joachim Kreuzburg joins Board of Directors — Board Update Summer 2025'.
  • IBA LifesciencesflagshipStrategic or Co-development PartnerCube Biotech completed the acquisition of IBA Lifesciences, with announcements titled 'Cube Biotech Completes Acquisition of IBA Lifesciences — Two leading innovators of biotech join forces' and 'We're Growing Better Together! Cube Biotech and IBA Lifesciences have joined forces!' (pop-up banner and News tile on the homepage). The two organizations now jointly market Strep-Tactin®XT and Twin-Strep-tag® products.
  • BayercoreStrategic or Co-development PartnerCo-development partnership with Bayer to develop eco-friendly pesticides using Cube Biotech's NativeMP™ platform to work on the Slo protein. Case study featured on the Membrane Protein Service page under 'Slo Protein for Bayer — We are developing eco-friendly pesticides to elevate agriculture to the next level'.
  • Orion PharmacoreStrategic or Co-development PartnerStrategic partnership with Orion Pharma (Espoo, Finland); referenced customer in R&D Target Pipeline with testimonial from Dr. Josef Messinger, Head of Structural Biology and Analytics. Logo featured on the Cube Biotech homepage and partner carousel.
  • Momentum BiotechnologiescoreStrategic or Co-development PartnerStrategic partnership series: Part II. Joint work on mass spectrometry-based drug discovery for membrane-bound proteins. Co-presented webinar 'Affinity Selection Mass Spectrometry (ASMS) High-Throughput Screening of the GLP1 Receptor' identifying small-molecule binders of GLP1R using NativeMP™ + customized AS-MS workflow.
  • NanoTemper TechnologiescoreTechnology or IntegrationStrategic technology partnership. Jointly published multiple application notes (App Note on NativeMP™ & Monolith X; App Note on NativeMP™ & Prometheus Panta for Cryo-EM workflows; App Note with Imperiali Lab at MIT for copolymer screening). Co-hosted webinars 'Optimization of Membrane Proteins for Cryo-EM with Nanotemper' and 'Breaking barriers in membrane protein drug discovery'.
  • X-ChemcoreStrategic or Co-development PartnerStrategic partnership series: Part V (September 2025). X-Chem is featured on the Drug Target Pipeline page as a fast-track drug discovery partner spanning target identification through hit-to-lead. Logo featured on the homepage partner carousel.
  • IktosminorStrategic or Co-development PartnerStrategic partnership series: Part III. AI-driven drug discovery collaboration; logo and announcement featured on the News page.
  • IsogenicaminorStrategic or Co-development PartnerStrategic partnership series: Part IV. Antibody / biologics discovery collaboration; featured as a news announcement on cube-biotech.com.
  • NanoImaging ServicesminorStrategic or Co-development PartnerStrategic partnership series: Part I. Cryo-EM services collaboration; featured as a news announcement on the Cube Biotech website.
  • ProteoGenixcoreStrategic or Co-development PartnerPartnership to produce target-specific antibodies via NativeMP™ platform plus ProteoGenix's phage display libraries and Xtencho™ platform. Co-developed 2 fully human antibodies against native human P2X4 (available for licensing). Co-hosted Intelligent Infusions webinar 'Next-Gen Antibody Discovery Enabled by the NativeMP™ & Phage Display Technology — P2X4 Case Study'.
  • edelrisminorStrategic or Co-development PartnerFeatured partner on the Drug Target Pipeline page (Fast-track drug discovery partners). Provides complementary drug discovery capabilities for the Cube Biotech pipeline.
  • Allegria TherapeuticsminorStrategic or Co-development PartnerConsortium partner with Cube Biotech and Fraunhofer ITMP in the MastCURe research consortium. Awarded €1.3M from the Eureka Eurostars program (April 2026) to develop novel mast-cell directed therapies for chronic urticaria, targeting aberrant mast cell activation in over 60 million patients worldwide.
  • Fraunhofer Institute for Translational Medicine and Pharmacology ITMP (Immunology and Allergology)minorStrategic or Co-development PartnerConsortium partner in the MastCURe research consortium with Allegria Therapeutics and Cube Biotech. Co-recipient of €1.3M Eureka Eurostars funding (April 2026) for mast-cell directed therapies for chronic urticaria.
  • Percorso Life SciencescoreChannel Partner/ Reseller/ DistributorPercorso Life Sciences has assisted Cube Biotech with their North American operations since 2013 (almost 10 years). Percorso facilitates order processing, inventory management and provides sales channels into the North American Life Science, Biotech and Pharmaceutical markets.
  • Fisher ScientificcoreChannel Partner/ Reseller/ DistributorCube Biotech products distributed globally via Fisher Scientific catalog (fishersci.com); prominently featured as 'Buy also at' partner on multiple product pages.
  • VWR / AvantorcoreChannel Partner/ Reseller/ DistributorCube Biotech products distributed via VWR / Avantor storefronts (us.vwr.com and avantorsciences.com); featured as 'Buy also at' partner on multiple product pages.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Cube Biotech competitors and assessment

Company assessment

Direct peers

  • Anatrace: Anatrace (acquired by Thermo Fisher Scientific) manufactures high-purity detergents and membrane protein reagents that are the conventional alternative to Cube Biotech's NativeMP™ copolymer nanodiscs. Both companies serve the same membrane protein research and structural biology customer base with overlapping product categories for GPCR, ion channel, and transporter workflows.
  • Avanti Polar Lipids: Avanti Polar Lipids (acquired by Croda) supplies lipids, detergents, and lipid nanoparticles for membrane protein research, cryo-EM, and drug delivery — directly adjacent to Cube Biotech's membrane protein stabilization and NativeMP™ copolymer portfolio. Both serve academic and pharma membrane protein labs with complementary lipid- and polymer-based tools.
  • IBA Lifesciences: IBA Lifesciences was acquired by Cube Biotech in 2025 and remains a key product brand within the combined portfolio. Prior to the acquisition it was a direct peer offering Strep-Tactin®XT / Twin-Strep-tag® affinity purification tools, and the two companies' customer bases and product lines are now fully integrated.

Broad incumbents

  • Cytiva: Cytiva (formerly GE Healthcare Life Sciences) is a large incumbent in protein purification and life sciences tools with broad portfolios in affinity chromatography, magnetic beads, and bioprocessing that overlap with Cube Biotech's PureCube Ni-INDIGO, Rho1D4, and Strep-Tactin®XT product lines. Cytiva competes on scale, catalog breadth, and bundled pricing in the same pharma and academic accounts.
  • Bio-Techne: Bio-Techne (NASDAQ: TECH) is a large protein research tools company offering recombinant proteins, antibodies, and assay reagents that overlap with Cube Biotech's NativeMP™ Targets catalog and Protein Service CRO offerings. Bio-Techne competes on catalog breadth and global distribution in academic and pharma protein research.
  • Sartorius AG: Sartorius is a major bioprocessing and lab products company offering protein purification, cell line development, and bioprocess tools that overlap with Cube Biotech's downstream purification portfolio and CRO services. The cross-membership of former Sartorius CEO Joachim Kreuzburg on Cube Biotech's Board underscores the strategic adjacency between the two companies in bioprocess and protein sciences.
  • Promega Corporation: Promega is a privately held life-sciences tools company offering protein analysis, purification, and detection reagents with overlapping applications in protein purification (His-tag, GST-tag) and cell-based assays. Promega competes with Cube Biotech's PureCube affinity resin line in mid-market and academic labs.
  • Merck KGaA (Sigma-Aldrich): Merck KGaA's life science business (including Sigma-Aldrich) is a global incumbent in research chemicals, reagents, and consumables with overlapping product categories in protein purification detergents, affinity resins, and standards. Sigma-Aldrich competes with Cube Biotech across academic and pharma catalog procurement.
  • Lonza Group: Lonza is a large contract development and manufacturing organization with adjacent capabilities in cell line engineering, protein expression, and bioprocess services. Lonza's protein production services overlap with Cube Biotech's CRO offering and drug target pipeline, and Lonza serves a similar pharma/biotech customer base.

Emerging players

  • NanoTemper Technologies: NanoTemper Technologies is a strategic technology partner of Cube Biotech with joint application notes on NativeMP™ and Monolith X (MST) and NativeMP™ and Prometheus Panta for Cryo-EM workflows. The companies jointly enable membrane protein characterization workflows, positioning NanoTemper as a complementary rather than directly competing peer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Cube Biotech social profiles

Digital presence

Cube Biotech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cube Biotech leadership team

Management profile

Number of profiles

Profiles8 records

Cube Biotech subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Cube Biotech funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cube Biotech M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cube Biotech

What does Cube Biotech do?

Cube Biotech develops, manufactures, and sells proprietary copolymer-based NativeMP™ reagents and consumables for stabilizing membrane proteins in their native lipid environment, complemented by affinity purification resins (PureCube Ni-INDIGO, Ni-NTA, Rho1D4, Strep-Tactin®XT), automated 96-well screening and purification plates (PlateX MP™ for liquid handling robots; NativeMP™ Plates for KingFisher Flex), off-the-shelf NativeMP™ stabilized protein targets, and quote-based custom membrane protein expression / purification CRO services. Its products are used by over 100 research institutions and pharmaceutical/biotech companies worldwide for cryo-EM, X-ray crystallography, antibody discovery, and drug discovery.

Is Cube Biotech a public or private company?

Cube Biotech is a private company. It is classified as private equity controlled and is currently operating.

When was Cube Biotech founded?

Cube Biotech was founded in 2012. It employs 51 to 100 people.

Where is Cube Biotech based?

Cube Biotech is headquartered in Monheim, Germany, in the Europe region.

How does Cube Biotech make money?

Four revenue lines are on record. Catalog Product Sales (Consumables & Kits) is the primary driver. The others are custom Membrane Protein CRO Services, OEM / Bulk Product Sales and nativeMP™ Target Protein Sales (High-value Catalog).

Who are Cube Biotech's main competitors?

Direct peers on record are Anatrace, Avanti Polar Lipids and IBA Lifesciences. Broad incumbents are Cytiva, Bio-Techne, Sartorius AG, Promega Corporation, Merck KGaA (Sigma-Aldrich) and Lonza Group. NanoTemper Technologies is listed as an emerging player.

Does Cube Biotech have an API?

No public API is recorded for Cube Biotech.

What industry is Cube Biotech in?

Cube Biotech's product category is Membrane Protein Research Reagents. Its primary akta.pro industry code is HLAGAAAD, Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity), with a secondary code of HLAAAJAI, Bioprocess Consumables & Reagents (resins, membranes, media components, buffers). Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AZoMA New Approach to Membrane Protein PurificationCyBio FeliX automation of Cube Biotech's NativeMP™ copolymer purification method purifies membrane proteins in under three hours, retaining native structure. The automated process yielded 2-38 times more protein per gram of cells than manual methods, with Western blot and cryo-EM validation.News-MedicalMembrane proteins in focusAnalytik Jena and Cube Biotech have developed a new automated workflow for membrane protein purification that can be completed in under three hours, compared to traditional methods that take days or weeks. The workflow combines Analytik Jena's CyBio FeliX automated liquid handling platform with Cube Biotech's polymer-based PlateX purification technology, using a detergent-free extraction strategy with copolymers to preserve native protein structure. Membrane proteins are targeted by approximately 60% of all approved drugs, making this advancement potentially significant for accelerating early-stage drug discovery and target validation in the pharmaceutical industry.BiotechniquesDriving innovation in lab automation and life sciences at SLAS Europe 2026The Society for Laboratory Automation and Screening (SLAS) held its 2026 European Conference and Exhibition in Vienna, Austria, with over 1,500 registrants from more than 30 countries and 137 exhibitors. Multiple companies launched new products including Omega Bio-tek, Bionomous, Cenevo, and Lutèce Dynamics, while award winners included Bionomous, Cube Biotech, and nNano AG for innovative lab automation solutions. Strategic partnerships were announced, including one between Cerillo Bio and Hamilton Company and another between Collaborative Drug Discovery and Lilly TuneLab, reflecting the industry's shift toward integrated, high-precision workflows and AI-enabled drug discovery platforms.News-MedicalSLAS celebrates innovative new products, startups and scientific excellence at European conference in ViennaSLAS (Society of Laboratory Automation and Screening) held its 2026 Europe Conference and Exhibition in Vienna from May 19–21, attracting 137 exhibitors and over 1,500 registrants from more than 30 countries. The event featured the Innovation AveNEW startup showcase, awarding the Ignite Award and €5,000 to Trince for its LumiPore photoporation platform, and presenting New Product Awards to Bionomous (Sortivo large-particle sorter), Cube Biotech (PlateX MP automated membrane protein purification plates), and nNano AG (CERTUS RIVO high-precision dispensing system). The conference also honored Niall McIntyre from Imperial College London with a Student Poster Award for his work on a high-throughput drug permeation screening platform.GenengnewsThe Protein Bottleneck: Why Discovery Slows Before It StartsThe article explains that producing stable, active membrane proteins, transcription factors, and ligases is a major bottleneck in drug discovery, delaying target validation and structural data. It highlights high costs and limited availability, and promotes a webinar from Cube Biotech and Nuclera on a rapid workflow to express these proteins in 48 hours.Towards HealthcareSmall Molecules Market to See Robust Growth by 2034A market research report projects the global small molecules market will experience significant expansion through 2034, driven by rising demand for chronic disease treatments and advancements in AI-driven drug discovery. Key growth areas include the oncology therapeutic segment and the Asia Pacific region, while strategic collaborations like the one between Iktos and Cube Biotech highlight industry innovation. The report identifies major pharmaceutical players such as Pfizer, AstraZeneca, and Jazz Pharmaceuticals as central to this evolving landscape.GlobeNewswireCube Biotech and X-Chem Partner to Enable DNA-encoded Library Screening of NativeMP™-stabilized Membrane ProteinsCube Biotech and X-Chem completed Project DEL-MP, proving DNA-encoded library screening works for membrane proteins stabilized with NativeMP copolymers. The collaboration validated hit discovery for targets like GLP1R, EGFR, and TNF, opening new drug discovery avenues.GlobeNewswireCube Biotech and X-Chem Partner to Enable DNA-encoded Library Screening of NativeMP™-stabilized Membrane ProteinsCube Biotech and X-Chem completed Project DEL-MP, proving that copolymer-stabilized membrane proteins can be screened with DNA-encoded libraries. The collaboration validated NativeMP technology for targets like GLP1R, EGFR, and TNF, enabling hit discovery for challenging targets.ContractpharmaCube Biotech Acquires IBA LifesciencesCube Biotech and IBA Lifesciences merged to create a unified entity focused on protein purification and stabilization. The combined company will leverage Cube's protein technologies and IBA's research tools to address researchers' needs. CEO Didier Dargent and Mike Rothe said the acquisition marks a new chapter for both companies.PR NewswireIktos and Cube Biotech Announce Launch of Small Molecule AI Drug Discovery CollaborationIktos and Cube Biotech announced a collaboration to discover small molecule agonists of the Amylin Receptor, combining Iktos's AI drug design with Cube Biotech's membrane protein technology. The partnership targets cardiometabolic disorders like obesity and diabetes, aiming to overcome limitations of existing GLP-1 therapies.